Pay in 4 interest-free payments of $6.93 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
Chronic Obstr
- What is the current evidence for the use of BPC 157
Careful consideration of dosages is essential to ensure safety and efficacy in clinical practice
Although the results for probing depth and gingival recession were not statistically significant, the single injection group demonstrated a significant therapeutic effect in improving bone defect depth (P = 0.0083)an outcome that is challenging to achieve with current non-surgical clinical treatments (Supplementary Table 11)
Injectable healing protocol: Dose: 2-3mg daily (higher end of range) Frequency: Daily throughout healing period Duration: Until wound resolves plus 1-2 weeks Injection site: Systemic (not into wound) Topical healing protocol: Concentration: 2-4% in wound-appropriate vehicle Application: 2-3 times daily to wound margins (not directly into open wounds) Duration: Throughout healing process Note: Consult healthcare provider for significant wounds GHK-CU pairs exceptionally well with BPC-157 and TB-500 for wound healing
US$ 20.62
US$ 22.86
US$ 23.97
US$ 27.27
